TheraRadar

Pipeline Activity Signals

SIGNALS

Companies with notable trial activity patterns (declining, stale, or concentrated late-stage)

0
Strong Signals
Multiple indicators
0
Moderate Signals
Activity declining
0
Early Signals
One indicator present
0
Total Flagged
Companies with signals

What These Signals Mean

We flag companies based on observable trial activity patterns:

  • Late-stage + declining activity: Companies with Phase 3 trials but no new starts
  • Completing without restarting: Trials ending but no new trials initiated
  • High value + slowing: Strong pipeline score but activity declining
  • Long dormancy: No trial activity for extended periods

Note: These patterns may indicate M&A activity, strategic pivots, funding challenges, or simply completion of development programs. Interpret with caution.

Disclaimer: This analysis is based on publicly available clinical trial data patterns. It does not constitute investment advice. Companies may have undisclosed activities or partnerships.